TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers.

Joshua T Kantrowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.